AstraZeneca taps Epsilon for consumer efforts

Share this content:

Pharmaceutical company AstraZeneca has expanded its long-running b-to-c marketing partnership with Epsilon to include efforts aimed directly at healthcare professionals.

Epsilon has been working with AstraZeneca on direct-to-consumer marketing, including e-mail and database efforts, since 2003. Now, the agency will use its database marketing, analytics and e-mail marketing capabilities to help AstraZeneca promote its top brands — including Nexium and Symbicort — to healthcare providers. The newly expanded partnership is expected to boost AstraZeneca's sales, support launches of new products and improve healthcare providers' knowledge of the products.

“Epsilon has been helping AstraZeneca connect with consumers for a number of years,” noted Lisa Henderson, SVP of client services at Epsilon. “This expansion is a natural step in our marketing partnership as the pharmaceutical industry looks to reach healthcare providers directly with valuable information.” Epsilon declined to comment further on this news, citing its client's wishes. AstraZeneca declined to comment.

The win signals Epsilon's growing strength in the pharma field. In June, the agency tapped Alex Kooluris as VP, general manager of Purple@Epsilon, with a particular focus on pharma clients. Kooluris had previously been with Saatchi and Saatchi and Glow Worm, where he worked on Johnson and Johnson and other marquee brands. Epsilon tapped another major healthcare talent, Saatchi & Saatchi Healthcare Communications' Andrew Bast, in March. Bast, who has experience working with clients like Nexium and Prilosec, became SVP, general manager at Purple@Epsilon, where he is responsible for healthcare clients.

“We continue to see significant multichannel marketing opportunities for the healthcare industry and to meet this growing demand Purple@Epsilon is adding new talent like Andrew Bast and now Alex Kooluris,” said David McRae, president, Purple@Epsilon, in a statement. “Our team understands the complexity of the industry and is well-positioned to meet the changing needs of clients to deliver marketing strategies that touch on a number channels, from direct marketing to advertising as well as interactive.”

AstraZeneca reported sales of $32 billion in 2008. The company's sales for the first quarter of 2009 were up by 7% over Q1 last year, to $7,701 million.


Next Article in Email Marketing

Sign up to our newsletters

Company of the Week

Since 1985, Melissa has helped thousands of companies clean, correct and complete contact data to better target and communicate with their customers. We offer a full spectrum of data quality solutions, including global address, phone, email, and name validation, identify verification - available for batch or real-time processes, in the Cloud or on-premise. Our service bureau provides dedupe, email/phone append and geographic/demographic append services for better targeting and insight. For direct mailers, Melissa offers easy-to-use address management/postal software, list hygiene services and 100s of specialty mailing lists - all with competitive pricing and excellent customer service.

Find out more here »

Career Center

Check out hundreds of exciting professional opportunities available on DMN's Career Center.  
Explore careers in digital marketing, sales, eCommerce, marketing communications, IT, data strategies, and much more. And don't forget to update your resume so employers can contact you privately about job opportunities.

>>Click Here

Relive the 2017 Marketing Hall of Femme

Click the image above